Partnership to Test Vaccine Candidates

Yerkes Regional Primate Research Center

Mary R. Galinski
A new partnership forming between Emory University's Vaccine Research Center in Atlanta and the Malaria Vaccine Initiative (MVI) in Rockville, Md., will enable the testing of several vaccine candidates developed by institutions worldwide. MVI, which is part of the Program for Appropriate Technology in Seattle that conducts health programs globally, will sponsor the effort. Mary R. Galinski, of the division of infectious diseases at Emory's Department of Medicine and an affiliate scientist at the Yerkes Regional Primate Research Center where the Vaccine Research Center is located, will lead the open-ended, multiyear effort. According to Galinski, the main focus will be on the two most predominant of the four human malaria species, Plasmodium falciparum and Plasmodium vivax, "Together these two species cause most of the annual estimated 300-500 million cases of malaria. Moreover, these two species...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?